Vivimed Labs Standalone March 2023 Net Sales at Rs 39.72 crore, down 25.23% Y-o-Y
June 01, 2023 / 13:57 IST
Reported Standalone quarterly numbers for Vivimed Labs are: Net Sales at Rs 39.72 crore in March 2023 down 25.23% from Rs. 53.12 crore in March 2022. Quarterly Net Loss at Rs. 264.85 crore in March 2023 down 1323.81% from Rs. 18.60 crore in March 2022. EBITDA stands negative at Rs. 163.77 crore in March 2023 down 14522.32% from Rs. 1.12 crore in March 2022. Vivimed Labs shares closed at 5.75 on May 29, 2023 (NSE) and has given -35.75% returns over the last 6 months and -56.11% over the last 12 months.
| Vivimed Labs | | Standalone Quarterly Results | in Rs. Cr. |
|
Story continues below Advertisement
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 39.72 | 50.56 | 53.12 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 39.72 | 50.56 | 53.12 | | EXPENDITURE | | Consumption of Raw Materials | 22.75 | 34.12 | 31.12 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 159.25 | 1.45 | 1.20 | | Power & Fuel | -- | -- | -- | | Employees Cost | 7.92 | 8.44 | 8.58 | | Depreciation | 95.07 | 3.80 | 4.66 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 13.58 | 12.71 | 13.91 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -258.84 | -9.97 | -6.34 | | Other Income | -- | 0.01 | 0.56 | | P/L Before Int., Excpt. Items & Tax | -258.84 | -9.96 | -5.78 | | Interest | 8.07 | 9.16 | 10.00 | | P/L Before Exceptional Items & Tax | -266.91 | -19.12 | -15.78 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -266.91 | -19.12 | -15.78 | | Tax | -2.07 | -- | 2.82 | | P/L After Tax from Ordinary Activities | -264.85 | -19.12 | -18.60 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -264.85 | -19.12 | -18.60 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -31.94 | -0.22 | -2.24 | | Diluted EPS | -31.01 | -0.23 | -2.18 | | EPS After Extra Ordinary | | Basic EPS | -31.94 | -0.22 | -2.24 | | Diluted EPS | -31.01 | -0.23 | -2.18 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
